Gebhardt, R., Hengstler, J.G., Müller, D., Glöckner, R., Buenning, P., Laube, P., Schmelzer, E., Ullrich. M., Utesch, D., Hewitt, N., Ringel, M., Hilz, B.R., Bader, A., Langsch, A., Koose, T., Burger, H.J., Maas, J., Oesch, F., 2003. New hepatocyte in vitro systems for drug metabolism: metabolic capacity and recommendations for application in basic research and drug development, standard operation procedures. Drug Metabol. Rev. 35(2-3), 145-213.
Hengstler, J.G., Van der Burg, B., Steinberg, P., Oesch, F., 1999. Interspecies differences in cancer susceptibility and toxicity. Drug Metab. Rev. 31(4), 917-970.
Yamazaki, K., Suzuki, M., Itoh, T., Matsumura, C., Nakano, T., Sakaki, T., Fukami, Y., Imaishi, H. & Inui, H., (2011): Structural basis of species differences between human and experimental animal CYP1A1s in metabolism of 3,3´,4,4´,5-pentachlorobophenyl. J. Biochem. 149(4): 487-494.
Keiser, M., Ullrich, A., Radebold, J., Damm, G., Nüssler, A. K., Siegmund, W. & Runge, D. (2012): The functionality of uptake transporters in primary hepatocytes of different species can be verified by Estrone-3-sulfate. Posterbeitrag International Society for the Study of Xenobiotics (ISSX).